
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
+14
Rhythm is a biopharmaceutical company aimed at developing and commercializing therapies for the treatment of rare MC4R pathway diseases. The company is leveraging the Rhythm Engine -- comprised of its TEMPO Registry, GO-ID genotyping study and Uncovering Rare Obesity program -- to improve the understanding, diagnosis and potentially the treatment of these disorders. For healthcare professionals, visit www.RareObesity.com for more information. For patients and caregivers, visit www.LEADforRareObesity.com for more information
Genetics,obesity,peptides,metabolism,rare disease,biotechnology,pharmaceuticals,research,health,medicine,clinical trials,endocrinology,orphan disease,science,advocacy,epidemiology,orphan drugs,rare disease,and metabolic
Rhythm pharmaceuticals inc operates in the Biotechnology research industry.
Rhythm pharmaceuticals inc's revenue is 101m - 500m
Rhythm pharmaceuticals inc has 201 - 500 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.